Price (delayed)
$21.53
Market cap
$920.75M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.49
Enterprise value
$937.52M
BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Its products and services portfolio includes its proprietary CryoStor® freeze media, HypoThermosol® shipping and storage
There are no recent dividends present for BLFS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.